Kansanterveyslaitos KTL

Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?

Lipsitch M; Whitney CG; Zell E; Kaijalainen T; Dagan R; Malley R
PLoS medicine : 1 (2005)

Avidity and Subclasses of IgG after Immunization of Infants with an 11-Valent Pneumococcal Conjugate Vaccine with or without Aluminum Adjuvant

Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
J Infect Dis : 184 (2001)

Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers

Ölander RM; Wuorimaa T; Käyhty H; Leroy O; Dagan R; Eskola J
Vaccine : 20 (2001)

Combined vacination of Haemophilus influenzae type b and diphtheria-tetanus-pertussis containing acellular pertusis

Eskola J; Ward J; Dagan R; Goldblatt D; Zepp F; Siegrist C-A
Lancet (1999)

Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine.

Wuorimaa TK; Dagan R; Bailleux F; Haikala R; Ekström N; Eskola J; Yaich M,; Käyhty H.
Vaccine : 46-47 (2005)

Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants

Puumalainen T; Dagan R; Wuorimaa T; Zeta-Capeding R; Lucero M; Ollgren J; Käyhty H; Nohynek H
Pediatr Infect Dis J : 2 (2003)

Otitis media and its consequences: beyond the earache. Review

Vergison A; Dagan R; Arguedas A; Bonhoeffer J; Cohen R; Dhooge I; Hoberman A; Liese J; Marchisio P; Palmu AA; Ray GT; Sanders EA; Simões EA; Uhari M; van Eldere J; Pelton SI
Lancet Infectious Diseases (2010)

Reduced response to multiple vaccines sharing common protein epitopes when administered simultaneously.

Dagan R; Eskola J; Leclere C; Leroy O
Infect Immun (1998)

Serological criteria for evaluation and licensure of pneumococcal conjugate vaccine formulations for use in infants.

Jodar L; Butler J; Carlone G; Dagan R; Frasch C; Goldblatt D; Käyhty H; Klugman K; Plikaytis B; Siber G; Kohberger R; Chang I; Cherian T
Vaccine (2003)

Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers

Wuorimaa T; Dagan R; Eskola J; Janco J; Åhman H; Leroy O; Käyhty H
Pediatr Infect Dis J : 3 (2001)

Tolerability and immunogenicity of an eleven-valent Streptococcus pneumoniae capsular polysaccharide diphtheria and tetanus conjugate vaccine in infants.

Dagan R; Käyhty H; Wuorimaa T; Yaïch M; Bailleux F; Zamir O; Eskola J
Pediatr Infect Dis J : 23 (2004)

Vaccination to reduce colonization of the nasopharynx by pneumococcus: a prevention strategy

Käyhty H; Auranen K; Nohynek H; Dagan R; Mäkelä H; for the Pneumococcal Carriage Group (PneumoCarr)
Expert Review of Vaccines (2006)

"Dagan R" - Selaus tekijän mukaan Kansanterveyslaitos KTL

Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? ﻿

Avidity and Subclasses of IgG after Immunization of Infants with an 11-Valent Pneumococcal Conjugate Vaccine with or without Aluminum Adjuvant ﻿

Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers ﻿

Combined vacination of Haemophilus influenzae type b and diphtheria-tetanus-pertussis containing acellular pertusis ﻿

Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine. ﻿

Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants ﻿

Otitis media and its consequences: beyond the earache. Review ﻿

Reduced response to multiple vaccines sharing common protein epitopes when administered simultaneously. ﻿

Serological criteria for evaluation and licensure of pneumococcal conjugate vaccine formulations for use in infants. ﻿

Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers ﻿

Tolerability and immunogenicity of an eleven-valent Streptococcus pneumoniae capsular polysaccharide diphtheria and tetanus conjugate vaccine in infants. ﻿

Vaccination to reduce colonization of the nasopharynx by pneumococcus: a prevention strategy ﻿